Sarepta Therapeutics Inc.
S&P 500SRPT/Healthcare · Biotechnology/NASDAQ
Stock Price
$16.02
Dividend Safety Rating
SRPT does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.
About Sarepta Therapeutics Inc.
Sarepta Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on developing and marketing therapies for rare diseases, with a strong emphasis on genetic and neuromuscular disorders. The company’s current portfolio includes approved treatments for Duchenne muscular dystrophy, alongside research programs in RNA-based medicines, gene therapy, and other genetic modalities. Sarepta Therapeutics also advances a broader pipeline for rare muscle and central nervous system diseases, reflecting its specialization in precision medicines for underserved patient populations. Its products and development efforts position the company as a notable participant in the rare-disease therapeutics market, where specialized science and targeted treatments are central to clinical and commercial activity.
Dividend Overview
Dividend Yield
0.00%
Annual Dividend
$0.00
Frequency
N/A
Payout Ratio
0.00%
FCF Payout Ratio
0.00%
52-Week Range
$10.42 - $25.32
Earnings & Profitability
SRPT earnings per share and net profit margin
Key Dates
Next Ex-Dividend Date
—
Next Payment Date
—
Dividend Growth
3-Year Dividend CAGR
N/A
5-Year Dividend CAGR
N/A
10-Year Dividend CAGR
N/A
3-Year Total Growth
N/A
5-Year Total Growth
N/A
10-Year Total Growth
N/A
Income Calculator
Frequently Asked Questions
What is SRPT's current dividend yield?
When is SRPT's next dividend payment date?
How much does SRPT pay in dividends per year?
Has SRPT been increasing its dividend?
Is SRPT's dividend safe?
How is SRPT's Dividend Safety Rating calculated?
Want to understand how we rate dividend safety? Read our full methodology
Track SRPT Dividends with OnlyDividends
What will SRPT actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.
This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.
Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.
Market data provided by Twelve Data.